APA (7th ed.) Citation

S, E., ES, A., C, Y., N, A., LK, B., A, A., . . . KN, W. (2025). Mpox virus (MPXV): Comprehensive analysis of pandemic risks, pathophysiology, treatments, and mRNA vaccine development. Naunyn-Schmiedeberg's archives of pharmacology, 398(6), 6143. https://doi.org/10.1007/s00210-024-03649-9

Chicago Style (17th ed.) Citation

S, Eslamkhah, Aslan ES, Yavas C, Akcalı N, Batur LK, Abuaisha A, Yildirim EE, Solak M, and White KN. "Mpox Virus (MPXV): Comprehensive Analysis of Pandemic Risks, Pathophysiology, Treatments, and MRNA Vaccine Development." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 6 (2025): 6143. https://doi.org/10.1007/s00210-024-03649-9.

MLA (9th ed.) Citation

S, Eslamkhah, et al. "Mpox Virus (MPXV): Comprehensive Analysis of Pandemic Risks, Pathophysiology, Treatments, and MRNA Vaccine Development." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 6, 2025, p. 6143, https://doi.org/10.1007/s00210-024-03649-9.